Daoyan Wei
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
Papers in ⓘ
-
- Cancer, Hypoxia, and Metabolism 13
- Cancer, Lipids, and Metabolism 8
-
- Cancer-related gene regulation 19
- Kruppel-like factors research 18
- Angiogenesis and VEGF in Cancer 10
- FOXO transcription factor regulation 6
- Co-authors
- Keping Xie (45 shared papers)Suyun Huang (26 shared papers)Xiangsheng Zuo (17 shared papers)Zhiliang Jia (26 shared papers)Xiangdong Le (19 shared papers)Yongmin Yan (4 shared papers)James C. Yao (12 shared papers)Allen C. Gao (2 shared papers)
- Journals
- Cancer Research (16 papers)Clinical Cancer Research (13 papers)Gastroenterology (4 papers)Clinical & Experimental Metastasis (4 papers)Oncogene (3 papers)
- Partner nations
- United StatesChinaSaudi Arabia
In The Last Decade
Daoyan Wei
73 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.7k
- Oncology 2.0k
- Molecular Biology 4.3k
- Pathology and Forensic Medicine 547
- Immunology 632
Countries citing papers authored by Daoyan Wei
This map shows the geographic impact of Daoyan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoyan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoyan Wei more than expected).
Fields of papers citing papers by Daoyan Wei
This network shows the impact of papers produced by Daoyan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoyan Wei. The network helps show where Daoyan Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Daoyan Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target Hit paper breakdown → | 2015 | 492 |
| 2 | 2003 | 464 | |
| 3 | 2004 | 460 | |
| 4 | Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. | 2003 | 297 |
| 5 | 2005 | 253 | |
| 6 | 2004 | 203 | |
| 7 | 2014 | 197 | |
| 8 | 2003 | 183 | |
| 9 | 2005 | 181 | |
| 10 | 2009 | 177 | |
| 11 | 2004 | 171 | |
| 12 | 2006 | 159 | |
| 13 | 2014 | 156 | |
| 14 | 2017 | 151 | |
| 15 | 2011 | 147 | |
| 16 | 2018 | 135 | |
| 17 | 2004 | 135 | |
| 18 | 2008 | 123 | |
| 19 | 2005 | 122 | |
| 20 | 2016 | 109 |
About Daoyan Wei
Daoyan Wei is a scholar working on Cancer Research, Molecular Biology, Oncology, Genetics and Biotechnology, having authored 75 papers that have together received 6.2k indexed citations. Recurring topics across this work include Cancer-related gene regulation (19 papers), Kruppel-like factors research (18 papers), Cancer, Hypoxia, and Metabolism (13 papers), Genetic Syndromes and Imprinting (12 papers), Angiogenesis and VEGF in Cancer (10 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer Cells and Metastasis (6 papers) and FOXO transcription factor regulation (6 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.0k citations), Molecular Biology (4.3k citations), Pathology and Forensic Medicine (547 citations) and Immunology (632 citations). Daoyan Wei has collaborated with scholars based in United States, China and Saudi Arabia. Frequent co-authors include Keping Xie, Suyun Huang, Xiangsheng Zuo, Zhiliang Jia, Xiangdong Le, Yongmin Yan, James C. Yao, Allen C. Gao, Weida Gong and Liwei Wang. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Gastroenterology, Clinical & Experimental Metastasis and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.